Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Nov 14;50(4):1903–1910. doi: 10.1167/iovs.08-2383

Figure 6.

Figure 6

Representative Western blot showing specific inhibition by (A) p38 MAPK (SB203580; 20 μM, designated SB) of phosphorylated p38 (p-p38), and (B) ERK1/2 (PD098059; 20 μM, designated PD) inhibition of phosphorylated ERK1/2 (p-ERK1/2) of ARPE-19 cells stimulated with CTGF.